Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
AbbVie eyes Qulipta expansion after menstrual migraine win
With positive phase 3 results in hand, AbbVie is one step closer to expanding the reach of its key migraine preventative Qulipta.
Fraiser Kansteiner
Sep 10, 2026 11:05am
Novartis investor calls for board overhaul after costly setbacks
Sep 10, 2026 10:26am
Designing an agentic, future‑ready tech roadmap for emerging pharma
Brought to you by
ZS
NICE rebuffs Gilead's twice-yearly PrEP option
Sep 10, 2026 10:12am
Pharma marketers face privacy hurdles, turn to omnichannel strategies
Brought to you by
Swoop
Samsung Bio nets $262M manufacturing deal with unnamed pharma
Sep 10, 2026 7:36am
